New York legalized recreational cannabis in 2021 through the Marihuana Regulation and Taxation Act (MRTA). As of 2025, the state has issued hundreds of new licenses, with sales surpassing $1 billion amid efforts to combat the illicit market.
New York's cannabis industry is driven by activists, entrepreneurs, and politicians focused on equity and reform.
Vladimir Bautista, CEO of Happy Munkey, promotes cannabis culture and small businesses.
Chris Webber, former NBA player, invests in equity-focused ventures like the Social Equity Fund.
Al Harrington, another ex-NBA star, founded Viola Brands emphasizing minority ownership.
New York's market features diverse brands emphasizing quality, equity, and innovation, available at licensed dispensaries.
STIIIZY leads with pods and pre-rolls, while Wyld excels in edibles.
Rythm and Jeeter are top for flower and infused products.
Ozone and Simply Herb offer affordable options, with MFNY and Alibi popular for pre-rolls.
New York's urban breeding scene has produced iconic strains, often potent and flavorful. Sour Diesel, originating in NYC, is a sativa staple with diesel aromas and energizing effects.
Lemon Cherry Gelato tops sales with sweet citrus notes and balanced highs.
New York's cannabis economy surpassed $1 billion in sales by early 2025, with projections of $1.3 billion for the year and $3.3 billion by 2027, contributing to national $31.4 billion growth.
Jobs increased 209% with new licenses, bucking national 3.4% dip to 425,000 total.
New York's cannabis industry in 2025 grapples with illicit market dominance, regulatory uncertainty, and federal banking restrictions under 280E, complicating operations.
Oversupply causes price volatility, while crackdowns on illegal sales aim to boost legal revenue.
